Alivus Life Sciences Ltd. NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Live Share Price Today, Share Analysis and Chart

Slowing Down Stock

about

Alivus Life Sciences is engaged in the business of development, manufacture and marketing of active pharmaceutical ingredients.

898.50 -2.30 (-0.26%)

28.18% Fall from 52W High

531.1K

NSE+BSE Volume

NSE 28 Nov, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

- / 100

Mid Valuation

- / 100

Technically Bearish

31.8 / 100

Slowing Down Stock These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time. View Similar Embed DVM

1Yr Price target upside is 44%

Alivus Life Sciences Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

132 Votes:

Buy 75.0%

Sell 12.12%

Hold 12.88%